Related Experiment Video
Updated: Jun 8, 2026
05:05
Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
Published on: June 17, 2025
[Cicatricial pemphigoid, mucous membrane pemphigoid]
Valérie Doffoel-Hantz1, Pierre-Yves Robert, Christophe Bédane
1CHU Dupuytren, centre de référence des maladies bulleuses auto-immunes, service de dermatologie, 87042 Limoges, France.
Presse Medicale (Paris, France : 1983)
|September 21, 2010
Summary
Mucous membrane pemphigoid is a rare blistering disease affecting mucous membranes, potentially causing scarring. Treatment focuses on anti-inflammatory and immunosuppressive drugs to limit fibrosis.
Area of Science:
- Immunodermatology
- Autoimmune Blistering Diseases
Background:
- Mucous membrane pemphigoid (MMP) is a sub-epidermal bullous disease.
- Characterized by mucosal inflammation, fibrosis, and scarring.
- Primarily affects oral mucosa and conjunctivas, with rare cutaneous involvement.
Purpose of the Study:
- To summarize the key features of mucous membrane pemphigoid.
- To highlight the therapeutic strategies for managing MMP.
- To emphasize the importance of limiting fibrotic complications.
Main Methods:
- Review of clinical characteristics of MMP.
- Analysis of treatment approaches for MMP.
- Discussion of the pathophysiology of autoimmune deposits in MMP.
Main Results:
- MMP presents with significant mucosal damage, leading to fibrosis.
- Oral and ocular mucosa are most commonly affected.
- Current treatments involve anti-inflammatory and immunosuppressive agents.
Conclusions:
- Effective management of MMP requires addressing both inflammation and fibrosis.
- Early intervention is crucial to prevent irreversible scarring.
- Further research into targeted therapies may improve outcomes for MMP patients.
Related Concept Videos
01:05Desmosomes
The term desmosome derives from the Greek words "desmo" and "soma" meaning "adhesion bodies." This structure was first observed during the late 1800s and described as small, dense nodules in the epidermis. Desmosomes are button-like structures that help form an interlinked network of intermediate filaments across the cells. These junctions are essential to hold cells together under mechanical stress and to maintain tissue integrity. Desmosomes are multi-protein complexes comprising desmosomal...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...
01:24Peptic Ulcer Disease II: Pathophysiology
Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
01:28Peptic Ulcer Disease II: Pathophysiology
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.